CVI Holdings’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

CVI Holdings’s Portfolio DMAQR Stock Details DMAQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-230,731	Closed	-$69.2K	–	200
2023 Q4	$69.2K	Hold	230,731	–	–	0.14%	39
2023 Q3	$69.2K	Hold	230,731	–	–	0.14%	47
2023 Q2	$36.9K	Hold	230,731	–	–	0.04%	90
2023 Q1	$32.3K	Hold	230,731	–	–	0.01%	189
2022 Q4	$11.5K	Hold	230,731	–	–	﹤0.01%	378
2022 Q3	$9K	Hold	230,731	–	–	﹤0.01%	647
2022 Q2	$25K	Hold	230,731	–	–	﹤0.01%	597
2022 Q1	$41K	Hold	230,731	–	–	﹤0.01%	660
2021 Q4	$74K	Buy	+230,731	New	+$73K	﹤0.01%	694

CVI Holdings's DMAQR Position: Q1 2024 in Review

CVI Holdings sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q1 2024, closing a stake of 230,731 shares — an estimated $69.2K sold.

CVI Holdings first reported a position in DMAQR in Q4 2021 and held it in 9 quarters. The position peaked at $74K in Q4 2021. 0 funds tracked by Wall St. Rank hold DMAQR as of Q1 2024.

CVI Holdings reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q1 2024 after selling out during the quarter.
CVI Holdings sold 230,731 Deep Medicine Acquisition Corp. Rights shares in Q1 2024, an estimated $69.2K.
CVI Holdings first reported a position in Deep Medicine Acquisition Corp. Rights in Q4 2021 and held it in 9 quarters.
CVI Holdings's Deep Medicine Acquisition Corp. Rights position peaked at $74K in Q4 2021.
0 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q1 2024.

Based on CVI Holdings's 13F filing for Q1 2024, filed 7 May 2024.